Amedica shares increased by 2,200.88% in the last 20 days, according to an FDA News Alert report.
Spinal Tech
Friedberg Investment Management has lowered its position in K2M Group stock by 8.2 percent during the fourth quarter, according to an Intercooler report.
Neurosurgery has published a peer-reviewed article regarding the cost-effectiveness of LDR's Mobi-C Cervical Disc.
Australian researchers invented a "bionic spine" for paraplegics, according to Fox News Healthth.
Zacks upgraded San Diego-based Cytori Therapeutics to a "buy" rating from a "hold" rating on Feb. 9, according to InterCooler.
Advertisement
Amedica is now in compliance with NASDAQ listing requirements after a period last year where the company's share price dipped below $1.
Ellipse Technologies withdrew its initial public offering yesterday, according to a Renaissance Capital report.
At the Arab Health Exhibition and Congress in Dubai, Medtronic launched its Valleylab FT10 energy platform, according to Trade Arabia.
Oppenheimer analysts reaffirmed Zimmer Biomet's "outperform" rating, according to Wallstreet.org.
Rick Pospisil, MD, of Huntington Beach (Calif.), is offering patients procedures to treat carpal tunnel syndrome.